← Open Payments lookup

CRISTY SHARP: Open Payments

NPI 1467475038 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$875 in 71 payments from 12 companies in 2025. Trend: 2023 $2,833 · 2024 $1,462 · 2025 $875

Food & beverage: $875
CompanyPaymentsAmount
ABBVIE INC.27$263
Novo Nordisk Inc11$157
AstraZeneca Pharmaceuticals LP6$147
Amgen Inc.18$145
GlaxoSmithKline, LLC.2$32
Almatica Pharma LLC1$30
PFIZER INC.1$20
Cleerly, Inc.1$19
Lilly USA, LLC1$18
Dexcom, Inc.1$15

Products named: QULIPTA, OTEZLA, BREZTRI, Rybelsus, UBRELVY, Ozempic, FARXIGA, REPATHA.

Industry payments across TX — which companies pay providers there.